224 related articles for article (PubMed ID: 20828784)
1. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater.
Escher BI; Baumgartner R; Koller M; Treyer K; Lienert J; McArdell CS
Water Res; 2011 Jan; 45(1):75-92. PubMed ID: 20828784
[TBL] [Abstract][Full Text] [Related]
2. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital.
Ort C; Lawrence MG; Reungoat J; Eaglesham G; Carter S; Keller J
Water Res; 2010 Jan; 44(2):605-15. PubMed ID: 19717180
[TBL] [Abstract][Full Text] [Related]
3. Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment.
Muñoz I; José Gómez M; Molina-Díaz A; Huijbregts MA; Fernández-Alba AR; García-Calvo E
Chemosphere; 2008 Dec; 74(1):37-44. PubMed ID: 18951608
[TBL] [Abstract][Full Text] [Related]
4. Multiple-criteria decision analysis reveals high stakeholder preference to remove pharmaceuticals from hospital wastewater.
Lienert J; Koller M; Konrad J; McArdell CS; Schuwirth N
Environ Sci Technol; 2011 May; 45(9):3848-57. PubMed ID: 21417333
[TBL] [Abstract][Full Text] [Related]
5. Monitoring, removal and risk assessment of cytostatic drugs in hospital wastewater.
Lenz K; Mahnik SN; Weissenbacher N; Mader RM; Krenn P; Hann S; Koellensperger G; Uhl M; Knasmüller S; Ferk F; Bursch W; Fuerhacker M
Water Sci Technol; 2007; 56(12):141-9. PubMed ID: 18075190
[TBL] [Abstract][Full Text] [Related]
6. Modeling of hospital wastewater pollution by pharmaceuticals: first results of Mediflux study carried out in three French hospitals.
Mullot JU; Karolak S; Fontova A; Levi Y
Water Sci Technol; 2010; 62(12):2912-9. PubMed ID: 21123922
[TBL] [Abstract][Full Text] [Related]
7. A comparison of human pharmaceutical concentrations in raw municipal wastewater and yellowwater.
Winker M; Faika D; Gulyas H; Otterpohl R
Sci Total Environ; 2008 Jul; 399(1-3):96-104. PubMed ID: 18455216
[TBL] [Abstract][Full Text] [Related]
8. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
9. Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization.
Schmitt H; Boucard T; Garric J; Jensen J; Parrott J; Péry A; Römbke J; Straub JO; Hutchinson TH; Sánchez-Argüello P; Wennmalm A; Duis K
Integr Environ Assess Manag; 2010 Jul; 6 Suppl():588-602. PubMed ID: 19958048
[TBL] [Abstract][Full Text] [Related]
10. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline.
Grung M; Källqvist T; Sakshaug S; Skurtveit S; Thomas KV
Ecotoxicol Environ Saf; 2008 Oct; 71(2):328-40. PubMed ID: 18068226
[TBL] [Abstract][Full Text] [Related]
11. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
12. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
Klecka G; Persoon C; Currie R
Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
[TBL] [Abstract][Full Text] [Related]
13. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
Daughton CG
Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
[TBL] [Abstract][Full Text] [Related]
15. Consumption-based approach for assessing the contribution of hospitals towards the load of pharmaceutical residues in municipal wastewater.
Le Corre KS; Ort C; Kateley D; Allen B; Escher BI; Keller J
Environ Int; 2012 Sep; 45():99-111. PubMed ID: 22580296
[TBL] [Abstract][Full Text] [Related]
16. The treatment of hospital wastewater: an appraisal.
Pauwels B; Verstraete W
J Water Health; 2006 Dec; 4(4):405-16. PubMed ID: 17176811
[TBL] [Abstract][Full Text] [Related]
17. Upflow anaerobic sludge blanket reactor--a review.
Bal AS; Dhagat NN
Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
[TBL] [Abstract][Full Text] [Related]
18. Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain).
Ginebreda A; Muñoz I; de Alda ML; Brix R; López-Doval J; Barceló D
Environ Int; 2010 Feb; 36(2):153-62. PubMed ID: 19931909
[TBL] [Abstract][Full Text] [Related]
19. Ecotoxicity tests in the environmental analysis of wastewater treatment plants: case study in Portugal.
Mendonça E; Picado A; Paixão SM; Silva L; Cunha MA; Leitão S; Moura I; Cortez C; Brito F
J Hazard Mater; 2009 Apr; 163(2-3):665-70. PubMed ID: 18691813
[TBL] [Abstract][Full Text] [Related]
20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]